Glaucomatous optic neuropathy: Mitochondrial dynamics, dysfunction and protection in retinal ganglion cells

WK Ju, GA Perkins, KY Kim, T Bastola, WY Choi… - Progress in retinal and …, 2023 - Elsevier
Glaucoma is a leading cause of irreversible blindness worldwide and is characterized by a
slow, progressive, and multifactorial degeneration of retinal ganglion cells (RGCs) and their …

Plasma membrane integrity in health and disease: significance and therapeutic potential

C Dias, J Nylandsted - Cell discovery, 2021 - nature.com
Maintenance of plasma membrane integrity is essential for normal cell viability and function.
Thus, robust membrane repair mechanisms have evolved to counteract the eminent threat of …

[HTML][HTML] The bidirectional interplay of α-Synuclein with lipids in the central nervous system and its implications for the pathogenesis of Parkinson's disease

K Battis, W **ang, J Winkler - International Journal of Molecular Sciences, 2023 - mdpi.com
The alteration and aggregation of alpha-synuclein (α-syn) play a crucial role in
neurodegenerative diseases collectively termed as synucleinopathies, including Parkinson's …

Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase

T Imberdis, J Negri, N Ramalingam… - Proceedings of the …, 2019 - pnas.org
Microscopy of Lewy bodies in Parkinson's disease (PD) suggests they are not solely
filamentous deposits of α-synuclein (αS) but also contain vesicles and other membranous …

Wild-type α-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding

H Long, W Zheng, Y Liu, Y Sun, K Zhao, Z Liu… - Proceedings of the …, 2021 - pnas.org
Heterozygous point mutations of α-synuclein (α-syn) have been linked to the early onset and
rapid progression of familial Parkinson's diseases (fPD). However, the interplay between …

A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein Mice

S Nuber, AY Nam, MM Rajsombath, H Cirka… - Annals of …, 2021 - Wiley Online Library
Objective Parkinson disease (PD) has useful symptomatic treatments that do not slow the
neurodegenerative process, and no significant disease‐modifying treatments are approved …

Phosphorylation of tau and α-synuclein induced neurodegeneration in MPTP mouse model of Parkinson's disease

S Hu, M Hu, J Liu, B Zhang, Z Zhang… - Neuropsychiatric …, 2020 - Taylor & Francis
Purpose Parkinson's disease (PD) is the second most common neurodegenerative disease.
The α-Synuclein is a major component of Lewy bodies and Lewy neurites, the pathologic …

Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson's disease

L Fonseca-Ornelas, T Viennet, M Rovere, H Jiang… - Cell reports, 2021 - cell.com
While misfolding of alpha-synuclein (αSyn) is central to the pathogenesis of Parkinson's
disease (PD), fundamental questions about its structure and function at the synapse remain …

Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions

I Lam, A Ndayisaba, AJ Lewis, YH Fu, GT Sagredo… - Neuron, 2024 - cell.com
The heterogeneity of protein-rich inclusions and its significance in neurodegeneration is
poorly understood. Standard patient-derived iPSC models develop inclusions neither …

Glycation of α-synuclein hampers its binding to synaptic-like vesicles and its driving effect on their fusion

AB Uceda, J Frau, B Vilanova, M Adrover - Cellular and Molecular Life …, 2022 - Springer
Parkinson's disease (PD) is one of the most prevalent neurodegenerative disorders affecting
the worldwide population. One of its hallmarks is the intraneuronal accumulation of insoluble …